Search

everythinglearnresearchcommunity

for

Search:↓

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Treat hair loss in postmenopausal women with diet, avoiding certain drugs, and using medications like minoxidil or finasteride.

High levels of cortisol in hair show long-term stress which can lower fertility in animals.

The main causes of hirsutism in Jordanian women are PCOS and idiopathic hirsutism.

PCOS is a common condition in women that can lead to infertility and other health issues, and it's diagnosed by specific criteria with various treatment options available.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.